The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: A pilot study

The requested reference [086539c0d36838a49e90451fd27fc4378ecdc9d6] no longer exists in our database. It has been replaced by the current reference: [c5e36d815f4aa74e33ed326c3f1c7a9c6153e899]

Authors
Category Primary study
JournalMultiple Sclerosis
Year 2002
Progressive axonal loss is the most likely pathologic correlate of irreversible neurologic impairment in primary progressive multiple sclerosis. In a run-in versus treatment trial, we show that the neuroprotective agent riluzole seems to reduce the rate of cervical cord atrophy and the development of hypointense T1 brain lesions on magnetic resonance imaging.
Epistemonikos ID: 07c73ebd0d1b6f4b9ff0c2209690dbb1228144b3
First added on: May 10, 2025